In the US, Deferiprone (deferiprone systemic) is a member of the following drug classes: antidotes, chelating agents and is used to treat Hemosiderosis, Iron Overload, Superficial Siderosis and Thalassemia.
- DEFERIPRONE 1000 MG FILM-COATED TABLETS (Leaflet)
- DEFERIPRONE 500 MG FILM-COATED TABLETS (Leaflet)
- DEFERIPRONE 500MG FILM-COATED TABLETS (Leaflet)
ATC (Anatomical Therapeutic Chemical Classification)
CAS registry number (Chemical Abstracts Service)
- Deferipronum (Latin)
- Deferipron (German)
- Défériprone (French)
- Deferiprona (Spanish)
- Deferiprone (OS: BAN, USAN)
- Défériprone (OS: DCF)
- Chelfer (IS)
- L1 (IS)
- Deferipron Evolan
Actavis UK, United Kingdom
- Deferiprone Lipomed
ApoPharma, Canada; ApoPharma, United States; Apotex, Australia; Apotex, China; Apotex, Czech Republic; Apotex, Estonia; Apotex, Greece; Apotex, Hong Kong; Apotex, Lithuania; Apotex, Norway; Apotex, New Zealand; Apotex, Oman; Apotex, Philippines; Apotex, Poland; Apotex, Singapore; Apotex, Thailand; Apotex, Tunisia; Apotex Europe, Cyprus; Apotex Nederland, Netherlands; Chiesi, Latvia; Chiesi, Turkey; Chiesi Farmaceutica, Brazil; Chiesi Farmaceutici, Italy; Pharma Logistics, Belgium; Quamed/Apotex, Indonesia; SOBI, Sweden; Sobi - Swedish Orphan Biovitrum, Germany; Swedish Orphan, Spain; Swedish Orphan Biovitrum, Denmark; Swedish Orphan Biovitrum, Finland; Swedish Orphan Biovitrum, France; Swedish Orphan Biovitrum, United Kingdom; Swedish Orphan Biovitrum Ltd., Ireland
- Ferriprox 100mg/ml
Apotex, Israel; Apotex, Oman; Apotex Europe, Austria; Pharma Logistics, Luxembourg
- Ferriprox 500mg
Apotex, Israel; Apotex Europe, Austria; Nordic, Switzerland; Swedish Orphan, Luxembourg
Cipla, Thailand; Cipla, Taiwan
|BAN||British Approved Name|
|DCF||Dénomination Commune Française|
|Rec.INN||Recommended International Nonproprietary Name (World Health Organization)|
|USAN||United States Adopted Name|
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.